Pfizer Opens Online Pharmacy to Fight Counterfeit Medicine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pfizer Opens Online Pharmacy to Fight Counterfeit Medicine


Pfizer has launched a prescription-fulfillment website for Viagra (sildenafil citrate) tablets in what the company describes as an effort to combat the online sale of counterfeited medicine. Patients with a valid prescription can purchase the drug online. CVS/pharmacy will handle the back-end functions, including the authentication of all prescriptions.

In a press statement, Pfizer reports that fake online pharmacies and the products they sell are an escalating public health threat. While the number of online pharmacies has increased in recent years to meet consumer demand, a recent review by the National Association of Boards of Pharmacy (NABP) has shown that as few as 3% of websites selling prescription drugs are legitimate pharmacies, and up to half offer foreign or non-FDA-approved drugs.

“We have seen counterfeit medicines manufactured in filthy and deplorable conditions, yet some people do not realize the risks that this poses to their health and safety, our top priority,” said Matthew Bassiur, vice president, Pfizer Global Security in the press release. “Counterfeit medicines often contain the wrong or incorrect levels of active ingredient, as well as potentially dangerous contaminants. Samples of counterfeit Viagra tested by our labs have contained pesticides, wallboard, commercial paint and printer ink. These findings motivate us to continue our aggressive global efforts to stop those who prey on unsuspecting patients.”

In 2011, Pfizer Global Security evaluated 22 websites appearing in the top search results for the phrase “buy Viagra” and conducted chemical analysis of the pills advertised as Pfizer’s Viagra that were ordered from these outlets. The study found that about 80% of these pills were counterfeit, and while the fake Viagra pills contained the active ingredient, sildenafil citrate, the amount was only 30% to 50% of what was advertised.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
28%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here